4.94

0.00% 0.00

After Hours: 5.05 0.11 +2.23%

Optimizerx Corp (OPRX)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Optimizerx Corp stock is traded at $4.94, with a volume of 340.92K. It is up +0.00% in the last 24 hours and down -27.35% over the past month. OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.

Previous Close:

$4.94

Open:

$4.92

24h Volume:

340.92K

Relative Volume:

0.65

Market Cap:

$92.70M

Revenue:

$109.43M

Net Income/Loss:

$5.13M

P/E Ratio:

18.96

EPS:

0.2606

Net Cash Flow:

$18.91M

1W Performance:

-5.18%

1M Performance:

-27.35%

6M Performance:

-66.14%

1Y Performance:

-59.14%

1-Day Range:

$4.90

$5.12

1-Week Range:

$4.71

$5.36

52-Week Range:

$4.57

$22.25

Optimizerx Corp Stock (OPRX) Company Profile

Name

Optimizerx Corp

Sector

Healthcare (1108)

Industry

Health Information Services (49)

Phone

248-651-6558

Address

260 CHARLES STREET, WALTHAM, MI

Employee

105

Twitter

@OpRxTweets

Next Earnings Date

2026-05-12

Latest SEC Filings

OPRX's Discussions on Twitter

Compare OPRX vs VEEV, BTSG, TEM, HQY, HNGE

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OPRX Optimizerx Corp	4.94	92.70M	109.43M	5.13M	18.91M	0.2606
VEEV Veeva Systems Inc	160.17	25.83B	3.20B	908.91M	1.39B	5.4168
BTSG Brightspring Health Services Inc	58.50	11.25B	13.65B	169.86M	412.12M	1.0758
TEM Tempus Ai Inc	46.18	8.35B	1.36B	-302.91M	-219.93M	-1.7182
HQY Healthequity Inc	88.11	7.25B	1.31B	215.20M	408.32M	2.4627
HNGE Hinge Health Inc	55.25	4.27B	646.34M	-512.40M	202.76M	-6.6871

Optimizerx Corp Stock (OPRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-08-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Dec-20-24	Initiated	Stephens	Equal-Weight
Jul-25-24	Resumed	B. Riley Securities	Buy
Apr-04-24	Initiated	JMP Securities	Mkt Outperform
Jan-03-24	Initiated	Barclays	Equal Weight
Feb-02-23	Resumed	B. Riley Securities	Buy
Nov-01-22	Initiated	Stifel	Buy
Jul-15-22	Initiated	SVB Leerink	Outperform
Oct-18-21	Resumed	B. Riley Securities	Buy
Apr-13-21	Initiated	RBC Capital Mkts	Outperform
Jan-03-19	Initiated	William Blair	Outperform

View All

Optimizerx Corp Stock (OPRX) Latest News

May 21, 2026

OptimizeRx Q1 earnings call highlights - MSN

May 21, 2026

OptimizeRx Corp. and DeepIntent Announce First Integration of EHR Network into Healthcare Advertising Platform - Quiver Quantitative

May 21, 2026

DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network - The Manila Times

May 21, 2026

OptimizeRx Corp. Integrates Proprietary Electronic Health Record Network Into DeepIntent Healthcare Advertising Platform - marketscreener.com

May 21, 2026

OPRX Technical Analysis | Trend, Signals & Chart Patterns | OPTIMIZERX CORP (NASDAQ:OPRX) - ChartMill

May 21, 2026

May 20, 2026

OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds - qz.com

May 20, 2026

OptimizeRx Corp. Sees Valuation Upgrade Amid Positive Financial Trends and High Institutional Confidence - Markets Mojo

May 20, 2026

OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold? - sharewise.com

May 20, 2026

May 19, 2026

OptimizeRx Corp stock (US6837631027): earnings momentum and buyback plan put focus back on digital h - AD HOC NEWS

May 19, 2026

May 18, 2026

OptimizeRx (OPRX) CCO logs Form 4 tax-withholding share dispositions - Stock Titan

May 18, 2026

OptimizeRx (OPRX) CEO has 5,219 shares withheld to cover RSU tax - Stock Titan

May 18, 2026

May 17, 2026

OptimizeRx's Q4 Beat: A Closer Look at the Numbers - Kavout

May 17, 2026

May 16, 2026

OptimizeRx Corp stock (US6837631027): earnings beat, buyback plan and volatile AI-health rally - AD HOC NEWS

May 16, 2026

May 15, 2026

OptimizeRx Cuts Revenue Outlook: Will Pressures Ease Ahead? - Yahoo Finance

May 15, 2026

Some OptimizeRx Corporation (NASDAQ:OPRX) Analysts Just Made A Major Cut To Next Year's Estimates - Yahoo Finance

May 15, 2026

May 14, 2026

OptimizeRx Corp stock (US6837631027): Bank note points to valuation reset - AD HOC NEWS

May 14, 2026

OptimizeRx (OPRX) Q1 2026 Earnings Transcript - The Globe and Mail

May 14, 2026

May 13, 2026

OptimizeRx Secures New Credit Facility to Boost Flexibility - The Globe and Mail

May 13, 2026

OptimizeRx Expands EHR Advertising Reach With New DSP Integration - qz.com

May 13, 2026

OptimizeRx (NASDAQ: OPRX) cuts Q1 loss as margins improve and debt refinanced - Stock Titan

May 13, 2026

Stifel cuts OptimizeRx stock price target on weaker guidance - Investing.com UK

May 13, 2026

B. Riley Adjusts Price Target on OptimizeRx to $10 From $11, Maintains Buy Rating - marketscreener.com

May 13, 2026

Stifel cuts OptimizeRx stock price target on weaker guidance By Investing.com - Investing.com Australia

May 13, 2026

OptimizeRx Corporation (NASDAQ:OPRX) Q1 2026 Earnings Call Transcript - Insider Monkey

May 13, 2026

OPRX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

May 13, 2026

OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance - The Manila Times

May 13, 2026

Earnings call transcript: OptimizeRx Q1 2026 beats estimates, stock rises - Investing.com UK

May 13, 2026

OptimizeRx Exceeds Expectations with Strong Q1 Growth - Intellectia AI

May 13, 2026

OptimizeRx Q1 Earnings Call Highlights - sharewise.com

May 13, 2026

May 12, 2026

Earnings Call Summary | OptimizeRx(OPRX.US) Q1 2026 Earnings Conference - Moomoo

May 12, 2026